Grace Borichevsky

2024

Journal - Research Article

Edwards, T. S., Ho, S. S. C., Brown, S. C., Appleton, L., Smith, B. R., Borichevsky, G. M., Swaminathan, A., Frampton, C. M. A., Gearry, R. B., Kettle, A. J., & Day, A. S. (2024). Fecal myeloperoxidase levels reflect disease activity in children with Crohn’s disease. Inflammatory Bowel Diseases. Advance online publication. doi: 10.1093/ibd/izae262

Swaminathan, A., Borichevsky, G. M., Frampton, C., Kettle, A. J., Peyrin-Biroulet, L., Siegel, C. A., Day, A. S., & Gearry, R. B. (2024). Development and investigation of a non-invasive disease severity index for inflammatory bowel disease. Journal of Crohn's & Colitis, jjae106. Advance online publication. doi: 10.1093/ecco-jcc/jjae106

Swaminathan, A., Borichevsky, G. M., Frampton, C. M., Day, A. S., Hampton, M. B., Kettle, A. J., & Gearry, R. B. (2024). Comparison of fecal calprotectin and myeloperoxidase in predicting outcomes in inflammatory bowel disease. Inflammatory Bowel Diseases. Advance online publication. doi: 10.1093/ibd/izae032

2023

Journal - Research Article

Swaminathan, A., Fulforth, J. M., Frampton, C. M., Borichevsky, G. M., Mules, T. C., Kilpatrick, K., … Gearry, R. B. (2023). The Disease Severity Index for inflammatory bowel disease is a valid instrument that predicts complicated disease. Inflammatory Bowel Diseases. Advance online publication. doi: 10.1093/ibd/izad294

Mules, T. C., Swaminathan, A., Hirschfeld, E., Borichevsky, G. M., Frampton, C. M., Day, A. S., & Gearry, R. B. (2023). The impact of disease activity on sexual and erectile dysfunction in patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 29, 1244-1254. doi: 10.1093/ibd/izac204

Journal - Research Other

Swaminathan, A., Frampton, C. M., Borichevsky, G. M., Kettle, A. J., & Gearry, R. B. (2023). Response to "Evaluating discriminative accuracy of biomarkers in relation to binary study outcomes: First validate, then celebrate?" Journal of Crohn's & Colitis, 17, 147-148. doi: 10.1093/ecco-jcc/jjac126

2022

Journal - Research Article

Swaminathan, A., Borichevsky, G. M., Edwards, T. S., Hirschfeld, E., Mules, T. C., Frampton, C. M. A., Day, A. S., Hampton, M. B., Kettle, A. J., & Gearry, R. B. (2022). Faecal myeloperoxidase as a biomarker of endoscopic activity in inflammatory bowel disease. Journal of Crohn's & Colitis, 16, 1862-1873. doi: 10.1093/ecco-jcc/jjac098

Swaminathan, A., Fan, D., Borichevsky, G. M., Mules, T. C., Hirschfeld, E., Frampton, C. M., Day, A. S., … Gearry, R. B. (2022). The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course. Alimentary Pharmacology & Therapeutics, 56, 664-674. doi: 10.1111/apt.17058

Mules, T. C., Swaminathan, A., Hirschfeld, E., Borichevsky, G., Frampton, C., Day, A. S., & Gearry, R. B. (2022). The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study. Alimentary Pharmacology & Therapeutics, 55, 201-211. doi: 10.1111/apt.16616

2021

Conference Contribution - Published proceedings: Abstract

Borichevsky, G., Swaminathan, A., Edwards, T., Day, A., Hampton, M., Kettle, A., & Gearry, R. (2021). Faecal myeloperoxidase is a biomarker of endoscopically active inflammatory bowel disease. Proceedings of the 16th Congress of the Federation of Asian & Oceanic Biochemists & Molecular Biologists (FAOBMB). (pp. 234). Retrieved from https://www.faobmb2021.org